Chronic Kidney Disease Flashcards
Role of Kidney
A WETBED
A WETBED
Acid base balance maintaining Water balance maintaining Electrolyte balance Toxin removal BP control Erythropoietin synthesis Vit D metabolism
CKD
Presence of: Kidney damage (albuminuria) OR Decreased kidney function (GFR<60 ml/minute per 1.73m2) for 3 months or more
CKD causes
Diabetes (40%) Hypertension (30%) Glomerulonephridites (7%) Polycystic kidney disease (3%) Chronic obstruction
CKD Stage 1
Normal eGFR (>90) With other evidence of kidney damage (persistent microalbuminuria or proteinuria, haematuria, structural abnormalities, biopsy proven glomerulonephritis)
CKD Stage 2
eGFR 60-90
With other evidence of kidney damage
CKD Stage 3a
eGFR 45-59
CKD Stage 3b
30-44
CKD Stage 4
eGFR 15-29
CKD Stage 5
eGFR < 15
CKD presentation
Commonly asymptomatic, picked up at screening
Non specific symptoms
CKD non specific symptoms
Fatigue Weakness Nausea Anorexia Dyspnoea Peripheral oedema Sore mouth Vomiting + diarrhoea Bad breath Increased thirst and urine production
CKD screening
Screen by checking GFR and urine albumin-creatinine ratio (ACR)
Patients at risk of CKD
AKI Diabetes Cardiovascular disease Structural kidney disease Uropathy (BPH, recurrent renal calculi) Multisystem disease with potential renal involvement (SLE etc)
CKD vs AKI
Important in patients presenting with renal dysfunction, but unknown baseline level
Can be difficult
CKD vs AKI distinguishing features
Clues include:
Non-specific symptoms of CKD (fatigue, weight loss, anorexia, nocturia, pruritic)
Presence of anaemia
Renal ultrasound- small kidneys? structural abnormalities?
CKD annual monitoring
eGFR
Urine albumin:creatinine ration (ACR)
- correlates with rate of progression of disease
- most reliable prognostic factor in CKD
CKD specialist referral when:
GFR<30 ACR>70mg/mmol ACR>30mg/mmol in presence of haematuria Hypertension despite 4 antihypertensives Accelerated progression of CKD- reduction of GFR by 25% with change in GFR category within 12 months, reduction in GFR of >-15 or more within 12 months
CKD management
Underlying cause
Slow progression
Manage complications
Renal replacement therapy
CKD- reducing albuminuria
ACE-inhibitors to patient with CKD and: - diabetes with albuminuria >30mg/mmol -hypertension and albuminuria >30mg/mmol -albuminuria >70mg/mmol Check GFR 1-2wks after starting ACE-Inh
CKD complications
Mineral bone disease CV disease Electrolyte disturbance Fluid disturbance Hypertension
CKD- Anaemia due to number of factors:
Reduced erythropoietin levels (normochromic normocytic anaemia)
Toxic effect of uraemia on bone marrow
Anorexia/nausea due to uraemia causing Vit deficiency
Reduced red cell survival (patients on haemodialysis)
–> may lead to LVH and 3x mortality rates
CKD anaemia- management
Ensure not iron deficient (and B12 + folate)
Give erythropoietin